Feed NLLSY
Summary
27 / 100 · Bulios Score
Valuation 68Growth 19Profitability 0Quality 2Debt 69Stability 10
What speaks for it
- It holds more cash than debt: 1.09B kr against 211.0M kr.
What to watch
- The company made a loss over the last 12 months.
- Revenue growth is slowing: 0.7% a year over the last 3 years against 10% over 5 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (NOK)
2021202220232024202520262027
Diluted EPS (NOK)
20212022202320242025
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 0.7% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 1.34B kr.
Profitability in detailIs it financially healthy?
YesCash and short-term investments 1.09B kr
Debt 211.0M kr
Free cash flow over 12 months -561.5M kr
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly negative- Buy 0
- Hold 0
- Sell 1
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.